|
 |
ZyfloThis page contains recent news articles, when available, and an overview of Zyflo but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.High-profile suicides also occurred in 2009 prompting the FDA to add black-box warnings to the asthma drugs Singulair, Accolate, and Zyflo and to the ... The Epoch Times Cornerstone Therapeutics Reports Third Quarter 2009 Financial Results - Nov 4, 2009 Zyflo CR® and Zyflo® net product sales were $5.0 million for the three months ended September 30, 2009. As noted below, the Company's historical financial ... Reuters Cornerstone Tops Zacks Ests - Nov 11, 2009 Zyflo CR and Zyflo revenues came in at $5 million for the reported quarter. Curosurf contributed $2.2 million to revenues during the quarter. ... Zacks.com Cornerstone Therapeutics Reports Third Quarter 2009 Financial Results - Nov 4, 2009 Zyflo CR and Zyflo net product sales were $5.0 million for the three months ended September 30, 2009. As noted below, the Company's historical financial ... MSN Money FDA reviewing safety of Singulair, Zyflo - Mar 27, 2008 By Val Brickates Kennedy, MarketWatch. BOSTON (MarketWatch) -- The Food and Drug Administration said Thursday it is investigating a possible link between ... MarketWatch Critical Therapeutics starts Zyflo CR study - Jul 10, 2007 Critical Therapeutics Inc. today announced the enrollment of the first patient in a new study designed to evaluate Zyflo CR, the name for an ... Boston Globe Critical Therapeutics expects $1.9M to $2.1M from Zyflo - Jan 9, 2007 Critical Therapeutics Inc. expects to report fourth-quarter revenue from its asthma drug Zyflo of $1.9 million to $2.1 million. ... Boston Globe Dey OK'd on Zyflo CR for asthma - May 31, 2007 NAPA, Calif., May 31 (UPI) -- US firm Dey said Thursday its marketing partner Critical Therapeutics has been approved to sell Zyflo CR for asthma in ... United Press International CRITICAL THERAPEUTICS GETS FDA APPROVAL FOR ZYFLO - Oct 11, 2005 Critical Therapeutics Inc. said that its Zyflo asthma drug will be available to consumers starting next week. On Sept. 28 the Lexington biotechnology ... $2.95 - Boston Globe - NewsBank Critical Therapeutics' ZYFLO(R) Receives Distinct Classification... - May 25, 2006 LEXINGTON, Mass. -- Critical Therapeutics, Inc. (Nasdaq: CRTX) today announced that the Centers for Medicare and Medicaid Services (CMS) has created a ... Free with registration - Business Wire - AccessMyLibrary.com FDA Investigates Merck Drug-Suicide Link - Mar 28, 2008 First approved in 1998, it's part of a class of asthma and allergy drugs that includes AstraZeneca's Accolate and Critical Therapeutics's Zyflo. ... FOXNews Critical Therapeutics markets new version of Zyflo - Sep 27, 2007 Critical Therapeutics Inc. and Dey LP said Thursday the companies have begun a nationwide launch of the asthma treatment Zyflo CR in extended-release, ... Bizjournals.com Critical Therapeutics Announces FDA Approval of ZYFLO(R) for the … - Sep 28, 2005 Critical Therapeutics, Inc. (Nasdaq: CRTX) announced today that the US Food and Drug Administration (FDA) has approved the Company's supplemental New Drug ... RedOrbit … NIH-Sponsored Study to Investigate the Efficacy Of ZYFLO(R) In... - Dec 15, 2006 ZYFLO, the immediate release tablet formulation of zileuton, ... ZYFLO is indicated for the prevention and chronic treatment of asthma in adults and ... Genetic Engineering News - Genetic Engineering News (press release) … Submits Supplemental New Drug Application to FDA for ZYFLO - Apr 1, 2005 ..."We anticipate launching ZYFLO in the second half of 2005, ... The FDA approved ZYFLO in 1996 for the prevention and chronic treatment of asthma in patients ... RedOrbit Critical Therapeutics gets $5M milestone payment from Mylan subsidiary... - Dec 10, 2007 Zyflo CR is Critical Therapeutics (nasdaq: CRTX - news - people )' formulation for the prophylaxis and chronic treatment of asthma in teenagers and adults. ... Forbes … open-label study of Zyflo; study provides certain patients' access... - Mar 14, 2005 Critical Therapeutics Inc has initiated an open-label, Phase IIIb study of its investigational drug, Zyflo Filmtab (zileuton tablets), for patients with ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com Critical Therapeutics Announces Research on ZYFLO(R) Presented at … - Mar 6, 2006 LEXINGTON, Mass. -- Critical Therapeutics, Inc. (Nasdaq: CRTX) today announced that two scientific posters on ZYFLO(R) (zileuton tablets) were presented at ... Free with registration - Business Wire - AccessMyLibrary.com Critical's Thomas leaving the CEO seat - May 2, 2008 Critical, which makes US Food and Drug Administration-approved Zyflo for asthma, reported a 2006 net loss of $48.8 million, on revenue of $13.1 million. ... Bizjournals.com … And Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton... - Sep 28, 2007 Dey, LP, an affiliate of Merck KGaA of Darmstadt, Germany, announced that it has launched ZYFLO CR(TM) (zileuton) extended release tablets with its ... Medical News Today - Medical News Today (press release) Chief executive of Critical Therapeutics resigns - Jun 26, 2006 ...the changes will help the company focus on the upcoming launch of the controlled-release formulation of its zileuton, or Zyflo, asthma treatment, ... Boston Globe Trial: Zyflo flunks mid-stage study for severe acne - Jul 13, 2005 Despite reducing lesions among patients with moderate to severe acne, Critical Therapeutics says that its mid-stage trial of Zyflo for acne failed to make a ... FierceBiotech … , DEY, LP, Launches US Sales and Marketing of ZYFLO(R) for Asthma - May 2, 2007 ..."The significant increase in the sales promotion effort behind ZYFLO should ... "At the same time, we expect ZYFLO to gain greater traction in the market as ... Genetic Engineering News - Genetic Engineering News (press release) … .(What's New)(Critical Therapeutics Inc. announces that sales of... - Mar 3, 2008 Zyflo tablets post big gains.(What's New)(Critical Therapeutics Inc. announces that sales of its Zyflo and Zyflo CR tablets increased)(Brief article) ... Pay-Per-View - Chain Drug Review - HighBeam Research Critical Therapeutics' Zyflo: good combo data.(Brief Article) - Nov 14, 2005 US drugmaker Critical Therapeutics says that new data presented on November 7 at the American College of Allergy, Asthma and Immunology's 2005 annual ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Critical Therapeutics reports good results on Zyflo trials - Sep 13, 2007 Critical Therapeutics Inc. said Thursday a recent Phase III trial of its asthma treatment Zyflo has yielded positive results. The Lexington, Mass. ... Boston Business Journal Critical Therapeutics Announces Acceptance of Controlled-Release … - Oct 17, 2006 Critical Therapeutics currently markets its asthma drug ZYFLO(R) (zileuton ... "We expect zileuton CR to build on the market penetration of ZYFLO and to ... Genetic Engineering News - Genetic Engineering News (press release) Critical Therapeutics Announces Results of Phase I/II Trial of... - Aug 23, 2006 ZYFLO is indicated for the prevention and chronic treatment of asthma in ... ZYFLO is the only 5-LO inhibitor approved for marketing by the US Food and Drug ... Free with registration - Business Wire - AccessMyLibrary.com FDA Investigating Singulair - Mar 28, 2008 If you take Singulair, Acolate, Zyflo or Zyflo CR and have noticed any changes in your mood or behavior, or if you have had suicidal thoughts, contact your ... HealthCentral.com … Announces the Publication of Data for ZYFLO CR(TM) (Zileuton) … - Jun 12, 2007 ZYFLO CR was approved by the US Food and Drug Administration (FDA) on May 30, 2007. ... ZYFLO CR and the immediate release formulation of zileuton, ZYFLO[R] ... $4.95 - Business Wire - ECNext Mastocytosis; Open-label study of ZYFLO begins - Apr 11, 2005 2005 APR 11 - (NewsRx.com) -- Critical Therapeutics, Inc., (CRTX) announced that it has initiated an open-label, phase IIIb study of its investigational ... Pay-Per-View - Respiratory Therapeutics Week - Factiva, from Dow Jones Critical Therapeutics Announces Change in Management - Mar 4, 2008 The Company owns worldwide rights to two FDA-approved drugs: twice-daily ZYFLO CR(TM) (zileuton) extended-release tablets and ZYFLO® (zileuton tablets). ... Lifescience-online Q1 2006 Critical Therapeutics, Inc. Earnings Conference Call - Final. - May 4, 2006 During the first six months of the US launch of ZYFLO, we've made steady ... The number of first-time ZYFLO prescribers continues to increase and now stands ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Critical Therapeutics Announces Enrollment in Phase III Trial of... - Oct 15, 2007 The purpose of this trial is to examine the effectiveness of ZYFLO at reducing the ... ZYFLO CRTM (zileuton) extended-release tablets and ZYFLO are the only ... RedOrbit … Studies Support Efficacy of Critical Therapeutics' ZYFLO in... - May 23, 2005 Critical Therapeutics, Inc. (Nasdaq: CRTX) today announced that scientific data were presented at the American Thoracic Society (ATS) 2005 International ... RedOrbit Critical Therapeutics Presents Safety Data for Twice Daily, Controlled... - Oct 25, 2006 ZYFLO(R) is indicated for the prevention and chronic treatment of asthma in ... ZYFLO is not indicated for use in the reversal of broncospasm in acute ... Genetic Engineering News - Genetic Engineering News (press release) Critical Therapeutics says FDA OK's partner's product - May 14, 2007 Wade said Critical needs to expand its sales force to start selling Perforomist and for that its needs approval of zileuton CR, the reformulation of ZYFLO, ... Reuters Asthma; FDA approves Zyflo for prevention and treatment of asthma - Nov 1, 2005 2005 NOV 1 - (NewsRx.com) -- Critical Therapeutics, Inc., (CRTX) announced that the US Food & Drug Administration (FDA) has approved the company's ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Critical Therapeutics to Present Data on ZYFLO(R) at the 2006 … - May 23, 2006 Critical Therapeutics, Inc. (NASDAQ: CRTX), a biopharmaceutical company focused on the discovery, development and commercialization of products for ... Genetic Engineering News - Genetic Engineering News (press release) Critical Therapeutics and Dey, LP Launch Perforomist(TM) (Formoterol ... - Oct 8, 2007 ZYFLO CR and ZYFLO are not indicated for use in the reversal of ... Therapy with ZYFLO CR and ZYFLO can be continued during acute exacerbations of asthma. ... Free with registration - Business Wire - AccessMyLibrary.com Q1 2005 Critical Therapeutics Inc. Earnings Conference Call - Final. - May 10, 2005 Approval of the NDA will allow us to market ZYFLO, which will be commercially ... Now in preparation for the launch of ZYFLO we've brought on all of our ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Critical Therapeutics to Present at the BIO CEO & Investor Conference... - Feb 15, 2006 ZYFLO is the only 5-lipoxygenase inhibitor approved for marketing by the US ... The Company's commercialization efforts for ZYFLO are carried out by its ... businesswire.com Zyflo tablets post big gains. - Mar 3, 2008 Zyflo tablets post big gains. Critical Therapeutics Inc. announced that sales of its Zyflo and Zyflo CR tablets increased about 43% for the four weeks ended ... $9.94 - Chain Drug Review - Alacra Store Biotech, pharma stocks mixed; Critical Thera soars. - Mar 14, 2007 The drug developer said that it will co-promote Zyflo in the US market with ... The deal also covers a new extended-released formulation of Zyflo and DEY's ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Critical Therapeutics Reports Second Quarter 2006 Financial Results - Jun 30, 2006 Critical Therapeutics began selling ZYFLO in the US in October 2005. Product sales of ZYFLO, net of returns, increased 77 percent to $1.8 million of total ... businesswire.com CT's acne drug Zyflo fails in Ph II trial.(Critical Therapeutics... - Jul 25, 2005 Critical Therapeutics of the USA says that data from a recent Phase II trial of its Zyflo Filmtab (zileuton) in patients with moderate-to-severe ... $4.95 - Pharma Marketletter - ECNext Press Release: FDA Approves ZYFLO CR(TM) (Zileuton) Extended- … - May 31, 2007 FDA Approves ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for Critical Therapeutics, DEY Marketing Partner for Chronic Treatment of Asthma. from PR ... Pay-Per-View - PR Newswire - HighBeam Research Critical Therapeutics Completes Phase I Clinical Trial of the R(+)... - Apr 8, 2008 The Company owns worldwide rights to two FDA-approved drugs: ZYFLO CR (zileuton) extended-release tablets and ZYFLO® (zileuton tablets). ... Lifescience-online Mastocytosis; Open-label study of ZYFLO begins - Apr 13, 2005 2005 APR 13 - (NewsRx.com) -- Critical Therapeutics, Inc., (CRTX) announced that it has initiated an open-label, phase IIIb study of its investigational ... Pay-Per-View - Immunotherapy Weekly - Factiva, from Dow Jones … and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton... - Sep 27, 2007 Dey LP and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research … Release: Critical Therapeutics' Twice-Daily ZYFLO CR(TM) (Zileuton)... - May 31, 2007 Critical Therapeutics' Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for Asthma Approved by FDA. from M2 Presswire. Pay-Per-View - M2 Presswire - HighBeam Research Press Release: Critical Therapeutics ZYFLO CR Extended-Release … - May 31, 2007 Critical Therapeutics ZYFLO CR Extended-Release Tables for Asthma Approved by FDA. from M2 Presswire. Highbeam Research – FREE Trial. Pay-Per-View - M2 Presswire - HighBeam Research Critical Therapeutics Initiates Phase II Clinical Trial for Zileuton... - Oct 3, 2007 ...our ability to successfully market and sell ZYFLO CR and ZYFLO, ... physician and third-party payor acceptance of ZYFLO CR and ZYFLO as safe and ... Free with registration - Business Wire - AccessMyLibrary.com WWAT, CRTX, ICPR, DHNA, HMIT "Red Hot Penny Stock Alert". - May 31, 2007 ZYFLO CR and ZYFLO are not indicated for use in the reversal of ... ZYFLO CR could potentially provide improved symptom control for those patients who still ... Free with registration - M2 Presswire - AccessMyLibrary.com Critical Therapeutics and DEY, LP Enter into Co-Promotion Agreement... - Mar 14, 2007 First, we immediately gain a co-promotion partner for ZYFLO and the support ... ZYFLO is the only 5-LO inhibitor approved for marketing by the US Food and ... Free with registration - Business Wire - AccessMyLibrary.com Press Release: Critical Therapeutics Announces NIH-Sponsored Study. -... - Dec 15, 2006 The Company owns worldwide rights to ZYFLO (zileuton tablets), which is marketed in the ... Representatives to Market ZYFLO CR in the U.S. LEXINGTON, Mass. ... Pay-Per-View - M2 Presswire - HighBeam Research Critical Therapeutics' Zileuton Provides Additional Asthma Control... - Jun 26, 2007 ZYFLO CR and ZYFLO are the only FDA-approved leukotriene synthesis inhibitors for the ... Therapy with ZYFLO CR and ZYFLO can be continued during acute ... RedOrbit Critical Therapeutics Achieves Collaboration Milestone in HMGB1 … - Dec 8, 2005 ZYFLO is the only 5-lipoxygenase inhibitor approved for marketing by the US ... The Company's commercialization efforts for ZYFLO are carried out by its ... biotech-intelligence.com Zacks Bull and Bear of the Day Highlights: IBM Corp., Liberty - Apr 1, 2008 The company has two products for asthma, Zyflo and Zyflo CR, on the market. ... However, sales of Zyflo/Zyflo CR fell short of our expectation. ... Bloomberg Critical Therapeutics' Juncture - May 7, 2007 However, even with the likely FDA approval, the controlled-release Zyflo still faces strong competition from Merck's (NYSE: MRK) Singulair. ... fool.com IV ZYFLO- GREAT POTENTIAL IN ER, BUT WILL THEY MARKET IT … - Oct 8, 2007 Zyflo is a great drug in its oral fornmaulation with goiod efficacy but has failed because one has to take it multiple times a day and because one has to ... Gerson Lehrman Group Q4 2006 Critical Therapeutics, Inc. Earnings Conference Call - Final. - Feb 8, 2007 Today, the sales and marketing efforts behind ZYFLO are planned to operate ... First, the number of ZYFLO prescriptions filled jumped to more than 9400 in ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Critical Therapeutics to Announce First-Quarter 2006 Financial... - Apr 20, 2006 The Company owns worldwide rights to the asthma drug ZYFLO(R) (zileuton ... ZYFLO is the only 5-lipoxygenase inhibitor approved for marketing by the US Food ... RedOrbit Critical Therapeutics Reports Financial Results for the Three and... - Nov 8, 2007 During the third quarter of 2007, product sales of ZYFLO[R] (zileuton tablets), ... Third quarter 2007 sales of ZYFLO CR included initial shipments to ... $4.95 - Business Wire - ECNext Zyflo cleared.(Critical Therapeutics Inc.'s asthma drug)(Brief... - Oct 24, 2005 Zyflo cleared.(Critical Therapeutics Inc.'s asthma drug)(Brief Article) ... find Chain Drug Review articles. Critical Therapeutics Inc. has announced ... Pay-Per-View - Chain Drug Review - HighBeam Research … Therapeutics.(Critical Therapeutics Inc. introduces Zyflo CR)(Brief... - Nov 12, 2007 Critical Therapeutics has begun launching its new product Zyflo CR, ... Zyflo CR is a twice-daily, extended-release tablet that is used for the treatment of ... Free with registration - Drug Store News - AccessMyLibrary.com Critical Therapeutics Receives Notice of Additional Deficiency from … - Aug 14, 2008 Critical Therapeutics owns worldwide rights to two FDA-approved drugs: ZYFLO CR(R) (zileuton) extended-release tablets and ZYFLO(R) (zileuton tablets). ... Genetic Engineering News - Genetic Engineering News (press release) SkyePharma's Zyflo CR debuts in USA. - Oct 8, 2007 The UK's SkyePharma and its US marketing partner, Critical Therapeutics, have launched their Zyflo CR (zileuton) extended-release tablets in the USA for the ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Article: Extended-release asthma tablets.(Products) - Pediatric News... - Nov 1, 2007 Products) ... find Pediatric News articles. The extended-release version of Zyflo (zileuton) tablets, Zyflo CR, is now for sale in the United States as a... Pay-Per-View - Pediatric News - HighBeam Research Article: Asthma drug.(RXs)(Brief article) - Chain Drug Review |... - Jun 25, 2007 Asthma drug.(RXs)(Brief article) ... find Chain Drug Review articles. Critical Therapeutics Inc. has received regulatory approval for Zyflo CR tablets. Pay-Per-View - Chain Drug Review - HighBeam Research Article: TAKING STOCK ; YOUR AT-A-GLANCE GUIDE - Evening … - Jun 1, 2007 EIExplorationInvestor: Critical Therapeutics ZYFLO CR Extended-Release Tables ... DEY), expects to begin marketing ZYFLO CR in the U.S. in the fall of 2007. ... Pay-Per-View - Evening Standard - London - HighBeam Research Critical Therapeutics Reports Fourth Quarter and Full Year 2005... - Dec 31, 2005 ZYFLO was approved for marketing by the US Food and Drug Administration (FDA) on ... "The US launch of ZYFLO highlighted a quarter in which we made steady ... businesswire.com Critical Therapeutics Completes Clinical Trial of Intravenous... - Jul 25, 2006 Mild to moderate side effects associated with the use of ZYFLO are abdominal ... A small percentage of patients treated with ZYFLO show an increased release ... Free with registration - Business Wire - AccessMyLibrary.com Press Release: Critical Therapeutics Inc Announces Data Publication. ... - Jun 13, 2007 ZYFLO CR was approved by the U.S. Food and Drug Administration (FDA) on May 30, 2007. ... ZYFLO CR and the immediate release formulation of zileuton, ZYFLO ... Pay-Per-View - M2 Presswire - HighBeam Research Zyflo CR.(FDA: actions in brief)(Brief article) - Jul 1, 2007 An extended-release formulation of zileuton (Zyflo CR, Dey/Critical Therapeutics) was approved for the prophylaxis and chronic treatment of asthma in adults ... Free with registration - Formulary - AccessMyLibrary.com Critical Therapeutics Completes Phase II Clinical Trial for Zileuton ... - Jun 2, 2008 Critical Therapeutics owns worldwide rights to two FDA-approved drugs: ZYFLO CR(TM) (zileuton) extended-release tablets and ZYFLO(R) (zileuton tablets). ... RedOrbit Press Release: Critical Therapeutics and Dey, LP Complete Definitive... - Jun 28, 2007 EIExplorationInvestor: Critical Therapeutics ZYFLO CR Extended-Release . ... Critical Therapeutics and its co ... plan to launch ZYFLO CR in the U.S. this ... Pay-Per-View - M2 Presswire - HighBeam Research Press Release: Analysis of Critical Therapeutics Inc. - M2 Presswire... - Jun 12, 2007 It markets ZYFLO, a tablet formulation of zileuton, which is used for the ... Critical Therapeutics and its co ... plan to launch ZYFLO CR in the U.S. this ... Pay-Per-View - M2 Presswire - HighBeam Research Asthma; Study looks at steroid-sparing effect of Zyflo in patients... - Dec 13, 2005 2005 DEC 13 - (NewsRx.com) -- Critical Therapeutics, Inc., (CRTX) announced the publication of a scientific poster demonstrating that asthma patients ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Zyflo CR Extended-Release Tablets. - Jul 9, 2007 Zyflo CR Extended-Release Tablets. Critical Therapeutics, Lexington, Mass., (781) 402-5700, with its promotion partner, Dey, L.P., will market twice-daily ... $9.94 - Drug Topics - Alacra Store Press Release: Focus List. - M2 Presswire | HighBeam Research: Online... - Jun 12, 2007 Critical Therapeutics, together with ... begin marketing ZYFLO CR in the U.S . ... Critical Therapeutics and its co ... plan to launch ZYFLO CR in the U.S. ... Pay-Per-View - M2 Presswire - HighBeam Research Press Release: WWAT, CRTX, ICPR, DHNA, HMIT "Red Hot Penny Stock … - May 31, 2007 Critical Therapeutics, together with ... begin marketing ZYFLO CR in the U.S . ... Critical Therapeutics and its co ... plan to launch ZYFLO CR in the U.S. ... Pay-Per-View - M2 Presswire - HighBeam Research Critical Therapeutics Files Controlled Release Formulation of... - Aug 1, 2006 The new formulation only needs to be taken twice a day whereas Zyflo(R), the currently marketed version of zileuton, has the drawback of requiring dosing ... Free with registration - PR Newswire - AccessMyLibrary.com Critical Therapeutics Reports Financial Results for the Quarter Ended... - Aug 8, 2007 DEY's 200-person sales force began promoting ZYFLO on April 30, 2007. For the three months ended June 30, 2007, sales of ZYFLO increased 28 percent to $2.3 ... $4.95 - Business Wire - ECNext Critical Therapeutics Inc Announces Data Publication. - Jun 13, 2007 ZYFLO CR was approved by the US Food and Drug Administration (FDA) on May 30, 2007. ... ZYFLO CR and the immediate release formulation of zileuton, ZYFLO ... Free with registration - M2 Presswire - AccessMyLibrary.com Critical Therapeutics, Inc. Announces Effectiveness of Registration … - Mar 10, 2008 These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this release. ZYFLO® and ZYFLO ... FINANZEN.NET NEWS - FINANZEN.NET NEWS Finance; Zyflo maker reports reports Q3 net loss of $6.6 million - Jan 3, 2005 2005 JAN 3 - (NewsRx.com & NewsRx.net) -- Critical Therapeutics, Inc., (CRTX), a biopharmaceutical company engaged in the discovery, development, ... Pay-Per-View - Biotech Business Week - Factiva, from Dow Jones CRITICAL THERAPEUTICS ANNOUNCES THE ISSUANCE OF FOUR … - Oct 10, 2007 ...maintain and enforce patent and other intellectual property protection for Alpha-7, HMGB1, ZYFLO CR, our discoveries and our drug candidates; ... Free with registration - Business Wire - AccessMyLibrary.com Finance; Zyflo maker reports reports Q3 net loss of $6.6 million - Jan 8, 2005 2005 JAN 8 - (NewsRx.com & NewsRx.net) -- Critical Therapeutics, Inc., (CRTX), a biopharmaceutical company engaged in the discovery, development, ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones First Twice-Daily Formulation Of Leukotriene Synthesis Inhibitor... - Jun 6, 2007 ZYFLO CR® and ZYFLO® are not indicated for use in the reversal of bronchospasm in ... "ZYFLO CR® has a unique mechanism of action that, combined with its ... Medical News Today - Medical News Today (press release) Zyflo CR. - Jul 1, 2007 An extended-release formulation of zileuton (Zyflo CR, Dey/Critical Therapeutics) was approved for the prophylaxis and chronic treatment of asthma in adults ... $9.94 - Formulary - Alacra Store CRITICAL THERAPEUTICS ANNOUNCES NIH STUDY OF ZYFLO - Dec 19, 2006 Critical Therapeutics has announced that the NIH will sponsor and fund a clinical trial to evaluate whether using Zyflo (zileuton tablets) to treat patients ... Pay-Per-View - FDAnews Drug Pipeline Alert - Factiva, from Dow Jones … Therapeutics' study suggests steroid-sparing effect of Zyflo in... - Nov 7, 2005 Zyflo is indicated for the prevention and chronic treatment of asthma in adults and children 12 years of age and older. Critical Therapeutics Inc is a ... Pay-Per-View - Company Reports - Factiva, from Dow Jones Zyflo CR.(FDA: actions in brief)(Brief article) - Jul 1, 2007 An extended-release formulation of zileuton (Zyflo CR, Dey/Critical Therapeutics) was approved for the prophylaxis and chronic treatment of asthma in adults ... $4.95 - Formulary - ECNext Zyflo cleared. - Oct 24, 2005 Critical Therapeutics Inc. has announced clearance of Zyflo for the prevention and chronic treatment of asthma. The oral drug reportedly blocks the ... $9.94 - Chain Drug Review - Alacra Store Critical Therapeutics and Dey, LP Complete Definitive Co-Promotion … - Jun 28, 2007 On March 13, 2007, Critical Therapeutics and DEY entered into an agreement for the joint promotion of ZYFLO[R] (zileuton tablets) and ZYFLO CR. ... Free with registration - Business Wire - AccessMyLibrary.com Critical Therapeutics to Report Third Quarter 2006 Financial Results... - Nov 2, 2006 The Company owns worldwide rights to ZYFLO(R) (zileuton tablets), which is marketed in the ... ZYFLO(R) is a registered trademark of Critical Therapeutics, Inc. Genetic Engineering News - Genetic Engineering News (press release) Extended-release asthma tablets.(Products) - Nov 1, 2007 The extended-release version of Zyflo (zileuton) tablets, Zyflo CR, is now for sale in the United States as a twice-daily medication for the prevention and ... $4.95 - Pediatric News - ECNext Critical Therapeutics sells shares to raise $54.5 million - Jun 8, 2005 Critical purchased Zyflo from Abbott Laboratories in 2004. ... Zyflo tablets are designed to decrease the number of acute attacks experienced by asthma ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones Critical Therapeutics Reports First Quarter 2005 Financial Results - Mar 31, 2005 ZYFLO currently is approved for the prevention and chronic treatment of asthma ... Critical Therapeutics plans to begin marketing ZYFLO in the United States ... businesswire.com CT launches Zyflo in USA at $7.30/day.(Critical Therapeutics Inc.)(Bri... - Oct 17, 2005 US drugmaker Critical Therapeutics says that it is ready to launch its drug Zyflo (zileuton) tablets, which is indicated for the prevention and chronic ... $4.95 - Pharma Marketletter - ECNext Critical Therapeutics Reports Financial Results for the Quarter Ended... - Mar 31, 2007 Through the end of 2006, revenue from product sales of ZYFLO was recognized ... The total number of ZYFLO prescriptions filled in the first quarter of 2007 ... RedOrbit Critical Thera up on Rhodia asthma agreement - Feb 11, 2005 ...manufacture of active pharmaceutical ingredients used in the production of various formulations of zileuton, including Zyflo filmtab (zileuton tablets), ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones Severe Asthma - Dec 11, 2007 I'm 30 w/ severe asthma - I take Advair, Zyflo, Zrytec, Sprivia, Prednisone, Albuterol/Atrovent (DuoNeb), Allergy Shots (weekly) Ativan and I am waiting on ... HealthCentral.com |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |